M45 Capital Partners, a Singapore-based multi-asset investment platform, has announced the appointment of Gordon Yeo as Partner and Head of Public Equities and Fundamental Research. Yeo, who brings over 14 years of experience from Arisaig Partners, will lead M45’s public equities platform and oversee the development of the M45 Global Compounder Fund. This fund is an unconstrained global public equity strategy aimed at long-term capital allocation.
Yeo’s role will also involve integrating insights across public markets, private investments, and credit, reinforcing M45’s cross-asset investment philosophy. His appointment is expected to deepen the firm’s sector and company-level research capabilities, enhancing its ability to identify and execute direct and co-investment opportunities.
Jason Kang, Founding Partner and Chief Investment Officer of M45 Capital Partners, expressed enthusiasm about Yeo’s addition, stating, “He brings deep institutional investing experience, a rigorous research mindset, and a long-term approach to capital allocation that aligns closely with the philosophy we are building at the firm.”
Yeo commented on his new role, saying, “M45 is building an investment platform centred on disciplined capital compounding and thoughtful risk management across cycles. By combining deep company research with insights drawn from both public and private markets, we believe we can develop a differentiated approach to long-term capital allocation for our partners.”
M45 Capital Partners plans to expand its investment team further, investing in talent and infrastructure to support its ambition of delivering a differentiated institutional-grade investment platform for families and long-term investors across Singapore and the broader region.
